Subscribe to our Newsletters !!
Cell therapy is a medical breakthrough in addressi
Chromium, a transition metal with profound pharmac
Few names in the medical history have had a profou
We are pleased to announce that we have recently e
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Mi
Seegene Inc Seol Korea based company used newly created artificial intelligence (AI)-based assay development system to develop two multiplexed molecular diagnostics for meningitis and Sexually transmitted Diseases.
The assays are based on Allplex real-time polymerase chain reaction (PCR) reagents designed to detect eight different DNA targets simultaneously.
The Seegene digitized development system automates real-time PCR assay development, driving down the cost of molecular diagnostic tests and enabling nonprofessionals to develop multiplexed assays.
The company’s pipeline of products includes assays that diagnose not only infectious diseases but also drug-resistant pathogens, genetic disorders, and various cancers, including breast, colon, and lung cancers.
For more information